Skip to main content
Erschienen in: Archives of Virology 8/2012

01.08.2012 | Original Article

HBV/D1: a major HBV subgenotype circulating in Uyghur patients with chronic HBV infection in Xinjiang, China

verfasst von: Jingjing Nie, Jie Li, Kuixia Sun, Mishu Sun, Jie Chen, Junfeng Ma, Ling Yan, Hui Zhuang

Erschienen in: Archives of Virology | Ausgabe 8/2012

Einloggen, um Zugang zu erhalten

Abstract

Each hepatitis B virus (HBV) genotype and subgenotype is associated with a particular geographic distribution, ethnicity, and anthropological history. The present study investigated the genomic characteristics of HBV from Uyghur patients with chronic HBV infection in Xinjiang, China. Among the 53 Uyghur patients enrolled, HBV/D was found to be the dominant strain, with 64.2 % (34/53), 60.4 % (32/53) with HBV/D1 and 3.8 % (2/53) with HBV/D3. In addition to these findings, 3.8 % HBV/B (2/53), 5.7 % HBV/C (3/53), 11.3 % C+D (6/53), 7.5 % B+D (4/53), 3.8 % B+C (2/53) and 3.8 % B+C+D (2/53) were also detected. The full-length genome of seven HBV/D1 isolates and 144 reference sequences retrieved from GenBank were compared and analyzed by biological information methods. These results demonstrate that the D1 isolates from Xinjiang and Central Asia show a close genetic proximity (0.013±0.0007). Furthermore, four unique amino acid substitutions (sp82Asn, sp89His, rt129Leu, rt151Leu) representing background polymorphisms rather than drug resistance mutations or immune escape variants were found in the Uyghur patients of Xinjiang, but these were seldom found in HBV/D1 strains from other regions (0 %-14.3 %). This study indicates that in Xinjiang, unlike HBV-infected Han patients, HBV/D1 is the predominant strain among HBV-infected Uyghur people. Although genetic distance analysis suggests that the HBV/D1 isolates from Xinjiang are closely related to those from Central Asia, unique amino acid substitutions suggest independent evolution of HBV in the Uyghur patients of Xinjiang.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Michitaka K, Tanaka Y, Horiike N, Duong TN, Chen Y, Matsuura K, Hiasa Y, Mizokami M, Onji M (2006) Tracing the history of hepatitis B virus genotype D in western Japan. J Med Virol 78:44–52PubMedCrossRef Michitaka K, Tanaka Y, Horiike N, Duong TN, Chen Y, Matsuura K, Hiasa Y, Mizokami M, Onji M (2006) Tracing the history of hepatitis B virus genotype D in western Japan. J Med Virol 78:44–52PubMedCrossRef
2.
3.
Zurück zum Zitat Shi Z, Li X, Ma L, Yang Y (2010) Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother-to-child transmission-a meta-analysis. Int J Infect Dis 14:e622–e634PubMedCrossRef Shi Z, Li X, Ma L, Yang Y (2010) Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother-to-child transmission-a meta-analysis. Int J Infect Dis 14:e622–e634PubMedCrossRef
4.
Zurück zum Zitat Shi Z, Yang Y, Ma L, Li X, Schreiber A (2010) Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis. Obstet Gynecol 116:147–159PubMedCrossRef Shi Z, Yang Y, Ma L, Li X, Schreiber A (2010) Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis. Obstet Gynecol 116:147–159PubMedCrossRef
5.
Zurück zum Zitat Arauz-Ruiz P, Norder H, Robertson BH, Magnius LO (2002) Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol 83:2059–2073PubMed Arauz-Ruiz P, Norder H, Robertson BH, Magnius LO (2002) Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol 83:2059–2073PubMed
6.
Zurück zum Zitat Huy TTT, Ngoc TT, Abe K (2008) New complex recombinant genotype of hepatitis B virus identified in Vietnam. J Virol 82:5657–5663CrossRef Huy TTT, Ngoc TT, Abe K (2008) New complex recombinant genotype of hepatitis B virus identified in Vietnam. J Virol 82:5657–5663CrossRef
7.
Zurück zum Zitat Norder H, Hammas B, Lofdahl S, Courouce AM, Magnius LO (1992) Comparison of the amino acid sequences of nine different serotypes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains. J Gen Virol 73:1201–1208PubMedCrossRef Norder H, Hammas B, Lofdahl S, Courouce AM, Magnius LO (1992) Comparison of the amino acid sequences of nine different serotypes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains. J Gen Virol 73:1201–1208PubMedCrossRef
8.
Zurück zum Zitat Okamoto H, Tsuda F, Sakugawa H, Sastrosoewignjo RI, Imai M, Miyakawa Y, Mayumi M (1988) Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol 69:2575–2583PubMedCrossRef Okamoto H, Tsuda F, Sakugawa H, Sastrosoewignjo RI, Imai M, Miyakawa Y, Mayumi M (1988) Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol 69:2575–2583PubMedCrossRef
9.
Zurück zum Zitat Stuyver L, De Gendt S, Van Geyt C, Zoulim F, Fried M, Schinazi RF, Rossau R (2000) A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol 81:67–74PubMed Stuyver L, De Gendt S, Van Geyt C, Zoulim F, Fried M, Schinazi RF, Rossau R (2000) A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol 81:67–74PubMed
10.
Zurück zum Zitat Liang XF, Bi SL, Yang WZ, Wang LD, Cui G, Cui FQ, Zhang Y, Liu JH, Gong XH, Chen YS, Wang FZ, Zheng H, Wang F, Guo J, Jia ZY, Ma JC, Wang HQ, Luo HM, Li L, Jin SG, Hadler SC, Wang Y (2009) Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine 27:6550–6557PubMedCrossRef Liang XF, Bi SL, Yang WZ, Wang LD, Cui G, Cui FQ, Zhang Y, Liu JH, Gong XH, Chen YS, Wang FZ, Zheng H, Wang F, Guo J, Jia ZY, Ma JC, Wang HQ, Luo HM, Li L, Jin SG, Hadler SC, Wang Y (2009) Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine 27:6550–6557PubMedCrossRef
11.
Zurück zum Zitat Li YJ, Zhuang H, Li J, Dong QM, Chen YJ, Niu JQ, Ma WM, Zhao W, Zhao BA, Zhong JQ (2005) Distribution and clinical significance of hepatitis B virus (HBV) genotypes and subtypes in HBV-infected patients. Chin J Hepatol 13:724–729 Li YJ, Zhuang H, Li J, Dong QM, Chen YJ, Niu JQ, Ma WM, Zhao W, Zhao BA, Zhong JQ (2005) Distribution and clinical significance of hepatitis B virus (HBV) genotypes and subtypes in HBV-infected patients. Chin J Hepatol 13:724–729
12.
Zurück zum Zitat Gao JW, Li YJ, Zhuang H, Li J, Wang J, Dong QM, Chen YJ, Niu JQ, Ma WM, Zhao W, Zhao BA, Zhong JQ (2007) Distribution of hepatitis B virus genotypes in patients with chronic hepatitis B virus infection among 12 cities in China. Chin J Epidemiol 28:315–318 Gao JW, Li YJ, Zhuang H, Li J, Wang J, Dong QM, Chen YJ, Niu JQ, Ma WM, Zhao W, Zhao BA, Zhong JQ (2007) Distribution of hepatitis B virus genotypes in patients with chronic hepatitis B virus infection among 12 cities in China. Chin J Epidemiol 28:315–318
13.
Zurück zum Zitat Zeng G, Wang Z, Wen S, Jiang J, Wang L, Cheng J, Tan D, Xiao F, Ma S, Li W, Luo K, Naoumov NV, Hou J (2005) Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China. J Viral Hepat 12:609–617PubMedCrossRef Zeng G, Wang Z, Wen S, Jiang J, Wang L, Cheng J, Tan D, Xiao F, Ma S, Li W, Luo K, Naoumov NV, Hou J (2005) Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China. J Viral Hepat 12:609–617PubMedCrossRef
14.
Zurück zum Zitat Zhou B, Xiao L, Wang Z, Chang ET, Chen J, Hou J (2011) Geographical and ethnic distribution of the HBV C/D recombinant on the Qinghai-Tibet Plateau. PLoS One 6:e18708PubMedCrossRef Zhou B, Xiao L, Wang Z, Chang ET, Chen J, Hou J (2011) Geographical and ethnic distribution of the HBV C/D recombinant on the Qinghai-Tibet Plateau. PLoS One 6:e18708PubMedCrossRef
15.
16.
Zurück zum Zitat Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association (2007) Guideline on prevention and treatment of chronic hepatitis B in China (2005). Chin Med J 120:2159–2173 Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association (2007) Guideline on prevention and treatment of chronic hepatitis B in China (2005). Chin Med J 120:2159–2173
17.
Zurück zum Zitat Gunther S, Li BC, Miska S, Kruger DH, Meisel H, Will H (1995) A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol 69:5437–5444PubMed Gunther S, Li BC, Miska S, Kruger DH, Meisel H, Will H (1995) A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol 69:5437–5444PubMed
18.
Zurück zum Zitat Tallo T, Tefanova V, Priimagi L, Schmidt J, Katargina O, Michailov M, Mukomolov S, Magnius L, Norder H (2008) D2: major subgenotype of hepatitis B virus in Russia and the Baltic region. J Gen Virol 89:1829–1839PubMedCrossRef Tallo T, Tefanova V, Priimagi L, Schmidt J, Katargina O, Michailov M, Mukomolov S, Magnius L, Norder H (2008) D2: major subgenotype of hepatitis B virus in Russia and the Baltic region. J Gen Virol 89:1829–1839PubMedCrossRef
19.
Zurück zum Zitat Saitou N, Nei M (1987) The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4:406–425PubMed Saitou N, Nei M (1987) The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4:406–425PubMed
20.
Zurück zum Zitat Kimura M (1980) A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 16:111–120PubMedCrossRef Kimura M (1980) A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 16:111–120PubMedCrossRef
21.
Zurück zum Zitat Xu H, Zhang YX, Wei L, Xiao L, Lu XB (2005) Relationship between the genotypes of hepatitis B virus and clinical courses in groups of the Han nationality in XinJiang. J Clin Hepatol 8:11–15 Xu H, Zhang YX, Wei L, Xiao L, Lu XB (2005) Relationship between the genotypes of hepatitis B virus and clinical courses in groups of the Han nationality in XinJiang. J Clin Hepatol 8:11–15
22.
Zurück zum Zitat Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, Robertson BH, Locarnini S, Magnius LO (2004) Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47:289–309PubMedCrossRef Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, Robertson BH, Locarnini S, Magnius LO (2004) Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47:289–309PubMedCrossRef
23.
Zurück zum Zitat Banerjee A, Kurbanov F, Datta S, Chandra PK, Tanaka Y, Mizokami M, Chakravarty R (2006) Phylogenetic relatedness and genetic diversity of hepatitis B virus isolates in Eastern India. J Med Virol 78:1164–1174PubMedCrossRef Banerjee A, Kurbanov F, Datta S, Chandra PK, Tanaka Y, Mizokami M, Chakravarty R (2006) Phylogenetic relatedness and genetic diversity of hepatitis B virus isolates in Eastern India. J Med Virol 78:1164–1174PubMedCrossRef
24.
Zurück zum Zitat Lusida MI, Nugrahaputra VE, Soetjipto Handajani R, Nagano-Fujii M, Sasayama M, Utsumi T, Hotta H (2008) Novel subgenotypes of hepatitis B virus genotypes C and D in Papua, Indonesia. J Clin Microbiol 46:2160–2166PubMedCrossRef Lusida MI, Nugrahaputra VE, Soetjipto Handajani R, Nagano-Fujii M, Sasayama M, Utsumi T, Hotta H (2008) Novel subgenotypes of hepatitis B virus genotypes C and D in Papua, Indonesia. J Clin Microbiol 46:2160–2166PubMedCrossRef
25.
Zurück zum Zitat Meldal BHM, Moula NM, Barnes IHA, Boukef K, Allain JP (2009) A novel hepatitis B virus subgenotype, D7, in Tunisian blood donors. J Gen Virol 90:1622–1628PubMedCrossRef Meldal BHM, Moula NM, Barnes IHA, Boukef K, Allain JP (2009) A novel hepatitis B virus subgenotype, D7, in Tunisian blood donors. J Gen Virol 90:1622–1628PubMedCrossRef
26.
Zurück zum Zitat Chu CJ, Keeffe EB, Han SH, Perrillo RP, Min AD, Soldevila-Pico C, Carey W, Brown RS, Luketic VA, Terrault N, Lok ASF (2003) Hepatitis B virus genotypes in the United States: results of a nationwide study. Gastroenterology 125:444–451PubMedCrossRef Chu CJ, Keeffe EB, Han SH, Perrillo RP, Min AD, Soldevila-Pico C, Carey W, Brown RS, Luketic VA, Terrault N, Lok ASF (2003) Hepatitis B virus genotypes in the United States: results of a nationwide study. Gastroenterology 125:444–451PubMedCrossRef
27.
Zurück zum Zitat Baig S, Siddiqui A, Chakravarty R, Moatter T (2009) Hepatitis B virus subgenotypes D1 and D3 are prevalent in Pakistan. BMC Res Notes 2:1PubMedCrossRef Baig S, Siddiqui A, Chakravarty R, Moatter T (2009) Hepatitis B virus subgenotypes D1 and D3 are prevalent in Pakistan. BMC Res Notes 2:1PubMedCrossRef
28.
Zurück zum Zitat Cooksley WGE (2010) Do we need to determine viral genotype in treating chronic hepatitis B? J Viral Hepatitis 17:601–610 Cooksley WGE (2010) Do we need to determine viral genotype in treating chronic hepatitis B? J Viral Hepatitis 17:601–610
29.
Zurück zum Zitat Comas D, Calafell F, Mateu E, Perez-Lezaun A, Bosch E, Martinez-Arias R, Clarimon J, Facchini F, Fiori G, Luiselli D, Pettener D, Bertranpetit J (1998) Trading genes along the silk road: mtDNA sequences and the origin of central Asian populations. Am J Hum Genet 63:1824–1838PubMedCrossRef Comas D, Calafell F, Mateu E, Perez-Lezaun A, Bosch E, Martinez-Arias R, Clarimon J, Facchini F, Fiori G, Luiselli D, Pettener D, Bertranpetit J (1998) Trading genes along the silk road: mtDNA sequences and the origin of central Asian populations. Am J Hum Genet 63:1824–1838PubMedCrossRef
30.
Zurück zum Zitat Chen BF, Liu CJ, Jow GM, Chen PJ, Kao JH, Chen DS (2006) High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology 130:1153–1168PubMedCrossRef Chen BF, Liu CJ, Jow GM, Chen PJ, Kao JH, Chen DS (2006) High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology 130:1153–1168PubMedCrossRef
31.
Zurück zum Zitat Ghany M, Liang TJ (2007) Drug targets and molecular mechanisms of drug resistance in chronic hepatitis B. Gastroenterology 132:1574–1585PubMedCrossRef Ghany M, Liang TJ (2007) Drug targets and molecular mechanisms of drug resistance in chronic hepatitis B. Gastroenterology 132:1574–1585PubMedCrossRef
32.
Zurück zum Zitat Bartholomeusz A, Schaefer S (2004) Hepatitis B virus genotypes: comparison of genotyping methods. Rev Med Virol 14:3–16PubMedCrossRef Bartholomeusz A, Schaefer S (2004) Hepatitis B virus genotypes: comparison of genotyping methods. Rev Med Virol 14:3–16PubMedCrossRef
33.
Zurück zum Zitat Naito H, Hayashi S, Abe K (2001) Rapid and specific genotyping system for hepatitis B virus corresponding to six major genotypes by PCR using type-specific primers. J Clin Microbiol 39:362–364PubMedCrossRef Naito H, Hayashi S, Abe K (2001) Rapid and specific genotyping system for hepatitis B virus corresponding to six major genotypes by PCR using type-specific primers. J Clin Microbiol 39:362–364PubMedCrossRef
Metadaten
Titel
HBV/D1: a major HBV subgenotype circulating in Uyghur patients with chronic HBV infection in Xinjiang, China
verfasst von
Jingjing Nie
Jie Li
Kuixia Sun
Mishu Sun
Jie Chen
Junfeng Ma
Ling Yan
Hui Zhuang
Publikationsdatum
01.08.2012
Verlag
Springer Vienna
Erschienen in
Archives of Virology / Ausgabe 8/2012
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-012-1325-8

Weitere Artikel der Ausgabe 8/2012

Archives of Virology 8/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.